Intriguingly, our study found that serum log10IL-8 levels were nominally elevated in MDD patients with SSRIs than in healthy controls, further suggesting that elevated IL-8 levels in patients with MDD might be modulated by SSRIs which activated the microglia and astrocytes of depression. This evidence concerns the gene CXCL8 and depressive symptom measurement.